. p38a plays a major role in the induction and maintenance of autophagy by MKK6. U2OS cells expressing a Tet-regulated construct were either mock treated (control) or treated with tetracycline for the indicated times to induce the expression of constitutively active MKK6. (A) Cells knockout for either p38a (p38a KO) or p38g (p38g KO) were generated from the U2OS cells expressing inducible MKK6 by using CRISPR/Cas9. Total lysates of the indicated KO or wild type (WT) cells were analyzed by immunoblotting at the indicated times after MKK6 induction. (B) Total lysates from cells WT, p38a KO or p38g KO either expressing MKK6 or not, were analyzed by immunoblotting using the indicated antibodies and the bands were quantified using LICOR Odyssey software. (C) Detection of LC3 + puncta (autophagosomes) by immunofluorescence in WT, p38a KO or p38g KO cells expressing MKK6 for 24 h in the presence or absence of the p38a inhibitors PH797804 (PH) or BIRB796 (BIRB). Bar = 10 µm. (D) Quantification of LC3 + puncta number and average size at 24 after MKK6 induction. Differences between control and MKK6 expressing cells or between the two groups indicated were analyzed using the unpaired Student t test, (***) p < 0.0001, (**) p < 0.001, (*) p < 0.01, ns, not significant. Supplementary Fig. 2 . Sustained p38a activity is required for autophagy. U2OS cells expressing a Tet-regulated construct were either mock treated (control) or treated with tetracycline for the indicated times to induce the expression of constitutively active MKK6. + puncta. Bar = 10 µm. (D) Saos-2 cells expressing the mCherry-GFP-LC3 reporter and MKK6 for the indicated times were analyzed by immunofluorescence. As a control, cells were starved in EBSS media for 8 h, which induced autophagy and increased the number of red dots, or autophagy was inhibited with bafilomycin A1 (BAF, 200 µM) for 4 h, which decreased the number of red dots. The histogram shows the quantification of the autophagic flux as determined by subtracting the number of green puncta from red puncta. Bar = 10 µm. Differences between control and MKK6 expressing cells were analyzed using the unpaired Student t test, (***) p < 0.0001, (**) p < 0.001. Supplementary Fig. 4 . MKK6-induced autophagosome formation is impaired in cells expressing the ULK1-S555A mutant. U2OS cells expressing a Tet-regulated construct were first treated with ULK1 siRNA and 48 h later were transfected with plasmids expressing wild type (WT) or the mutant form S555A of ULK1. After 24 h, cells were either mock treated (control) or treated with tetracycline for 48 h to induce the expression of constitutively active MKK6. LC3 + puncta (autophagosomes) were detected by immunofluorescence using LC3 antibodies. The histogram shows the quantification. Bar = 10 µm. Differences between control and MKK6 expressing cells, or between the two groups indicated were analyzed using the unpaired Student t test, (***) p < 0.0001, (*) p < 0.01. (A) U2OS cells expressing a Tet-regulated construct were treated either with control (mock) or p53 siRNAs and 48 h later were treated with tetracycline for 48 h to induce the expression of constitutively active MKK6. Cell lysates were analyzed by immunoblotting using the indicated antibodies. (B) Cells treated as in (A) were analyzed for cell death as determined by FACS using Annexin V/PI staining. (C) Cells treated as in (A) were analyzed for senescence by β-gal staining. Differences between MKK6-expressing cells treated with control or p53 siRNAs were analyzed using the unpaired Student t test, (**) p < 0.001; ns, not significant. Supplementary Fig. 8 . Inhibition of p38a activity sensitizes cancer cells to apoptosis. (A) A549 cells were treated with doxorubicin (Dox, 250 nM) for 48 h in the presence or absence of the p38a inhibitors BIRB-796 (BIRB) and LY2228820 (LY), and then were analyzed by FACS using Annexin V/PI staining. (B and C) U2OS cells were treated with camptothecin (CPT, 500 nM) (B) or palbociclib (PALB, 15 µM) (C) for 48 h in the presence or absence of the p38a inhibitors BIRB and LY, and then were analyzed by FACS using Annexin V/PI staining to determine cell death. (D) U2OS cells were treated with control or ATG5 siRNA and 48 h later were treated with Dox. After 48 h cell death was determined by FACS using Annexin V/PI staining. Differences between two groups of cells subjected to various treatments were analyzed using the unpaired Student t test, (****) p < 0.00001, (***) p < 0.0001, (**) p < 0.001, (*) p < 0.01.
